The Center for Research on Influenza Pathogenesis and Transmission (CRIPT) is one of five Centers of Excellence for Influenza Research and Response (CEIRR) funded by the National Institute of Allergy and Infectious Diseases (NIAID). CRIPT pursues a three-part mission of research, training and services.
Our Research focuses on unique, multidisciplinary, and international basic and clinic influenza program to study the evolution, pathogenesis and transmission of influenza viruses in humans as well as at distinct zoonotic interfaces.
Training in the Center facilitates faculty development and educates future scientific leaders in the field. Our trainees pursue successful careers in academia, industry and governments worldwide.
CRIPT provides services and expertise that complements ongoing public health programs to rapidly respond to emerging human respiratory pathogens of pandemic potential, including influenza virus. This is achieved through a combination of inter-related human studies to understand the factors contributing not only to zoonotic emergence but also to disease severity, transmission, and immune protection by previous infection and/or vaccination.
Our Mission
-
Provide the research expertise, tools, facilities, and knowledge to rapidly respond to pre-pandemic and pandemic events to mitigate the public health impact of such events, including the COVID-19 pandemic.
-
Serve as a resource to the scientific community. Provide a repository for viral isolates, serum samples, antibodies, purified proteins, and reagents through Biodefense and Emerging Infections Resources (BEI) as well as access to viral sequence analysis and phylogenetics through the Influenza Research Database (IRD).